Microfluidics

Microfluidics

Global Microfluidics Market to Reach $123.1 Billion by 2030
The global market for Microfluidics estimated at US$43.4 Billion in the year 2023, is expected to reach US$123.1 Billion by 2030, growing at a CAGR of 16.1% over the period 2023-2030. Microfluidics Devices, one of the segments analyzed in the report, is expected to record 14.5% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth in the Microfluidics Components segment is estimated at 17.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $11.3 Billion, While China is Forecast to Grow at 20.5% CAGR
The Microfluidics market in the U.S. is estimated at US$11.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$30.2 Billion by the year 2030 trailing a CAGR of 20.5% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.4% and 14.6% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 13.5% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cellix Biosciences Inc,
  • Danaher Corporation
  • Dolomite Microfluidics
  • Elveflow
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • Illumina, Inc.
  • Microfluidic ChipShop GmbH
  • Micronit Microtechnologies
  • PerkinElmer, Inc.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Microfluidics - Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for In-Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for In-Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for In-Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Microfluidics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 5: World Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical & Life Science Research and Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Pharmaceutical & Life Science Research and Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Pharmaceutical & Life Science Research and Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 21: USA Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: USA 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: Canada 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
JAPAN
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Japan 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
CHINA
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: China Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: China 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
EUROPE
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Europe 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Microfluidics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
FRANCE
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 53: France Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: France Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: France 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
GERMANY
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 59: Germany Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Germany 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Italy 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
UNITED KINGDOM
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 71: UK Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: UK Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: UK 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
SPAIN
TABLE 77: Spain Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Spain 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 80: Spain Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Spain 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
RUSSIA
TABLE 83: Russia Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Russia 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 86: Russia Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Russia 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Rest of Europe 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of Europe 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Asia-Pacific 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Microfluidics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Asia-Pacific 16-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
AUSTRALIA
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 104: Australia Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Australia 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 107: Australia Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Australia Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Australia 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
INDIA
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 110: India Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: India Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: India 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 113: India Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: India Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: India 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 116: South Korea Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: South Korea 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 119: South Korea Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: South Korea Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: South Korea 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Asia-Pacific Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
LATIN AMERICA
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 128: Latin America Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Latin America 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Microfluidics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Latin America 16-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 134: Latin America Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 137: Argentina Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Argentina 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 140: Argentina Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Argentina Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Argentina 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
BRAZIL
TABLE 143: Brazil Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Brazil 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 146: Brazil Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Brazil Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Brazil 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
MEXICO
TABLE 149: Mexico Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Mexico 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 152: Mexico Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Mexico Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Mexico 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Rest of Latin America 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Rest of Latin America Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Rest of Latin America 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
MIDDLE EAST
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 161: Middle East Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Middle East 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Microfluidics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Microfluidics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Middle East 16-Year Perspective for Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 167: Middle East Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
IRAN
TABLE 170: Iran Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Iran 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 173: Iran Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Iran Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Iran 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
ISRAEL
TABLE 176: Israel Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Israel 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 179: Israel Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Israel Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Israel 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Saudi Arabia 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Saudi Arabia Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Saudi Arabia 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 188: UAE Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: UAE 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 191: UAE Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: UAE Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: UAE 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Middle East 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Middle East Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Middle East 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
AFRICA
Microfluidics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 200: Africa Recent Past, Current & Future Analysis for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Microfluidics by Application - In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Africa 16-Year Perspective for Microfluidics by Application - Percentage Breakdown of Value Sales for In-Vitro Diagnostics, Pharmaceutical & Life Science Research and Manufacturing and Therapeutics for the Years 2014, 2024 & 2030
TABLE 203: Africa Recent Past, Current & Future Analysis for Microfluidics by Offering - Devices and Components - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Africa Historic Review for Microfluidics by Offering - Devices and Components Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Africa 16-Year Perspective for Microfluidics by Offering - Percentage Breakdown of Value Sales for Devices and Components for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings